Makes Disturbances Melt Away?
July 24, 2010 12:33 AM Subscribe
In a pilot Phase II study
of PTSD sufferers with a median of 19 years since diagnosis, MDMA-assisted therapy resulted in 10 out of 12 patients no longer meeting the diagnostic criteria.
Full paper PDF here
Mean CAPS scores in the active arm reduced from 79 to 25, and 79 to 59 in the placebo group.
One requirement of the study protocol was hospitalization for 24 hours from the time of dosing. Some may find this an expensive constraint to adoption of MDMA as therapy adjunct.
Check out MAPS
for more details on studies involving MDMA.
Previously on the Blue